Skip to main content

Table 6 Odds Ratios for All-Cause Discontinuation and Discontinuation Due to Adverse Events

From: Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis

PLO 1.68 [1.09, 2.48] 1.05 [0.77, 1.41] 0.70 [0.48, 1.00] 0.99 [0.78, 1.24] 1.38 [0.92, 1.98] 1.10 [0.61, 1.83]
2.47 [1.10, 4.90] ARI 0.66 [0.38, 1.06] 0.44 [0.24, 0.73] 0.62 [0.37, 0.96] 0.86 [0.47, 1.45] 0.68 [0.32, 1.28]
1.50 [0.82, 2.64] 0.70 [0.25, 1.64] CAR 0.68 [0.42, 1.06] 0.96 [0.64, 1.37] 1.34 [0.79, 2.11] 1.07 [0.54, 1.90]
1.43 [0.68, 2.58] 0.67 [0.21, 1.57] 1.04 [0.37, 2.23] OLA 1.46 [0.93, 2.18] 2.03 [1.15, 3.30] 1.62 [0.79, 2.95]
2.46 [1.57, 3.75] 1.15 [0.44, 2.49] 1.79 [0.80, 3.42] 1.93 [0.82, 4.09] QUE 1.41 [0.88, 2.15] 1.12 [0.59, 1.95]
1.54 [0.76, 2.80] 0.72 [0.23, 1.70] 1.12 [0.41, 2.37] 1.21 [0.43, 2.82] 0.66 [0.27, 1.32] ZIP 0.83 [0.40, 1.54]
1.12 [0.36, 2.76] 0.52 [0.12, 1.50] 0.81 [0.21, 2.23] 0.88 [0.22, 2.50] 0.48 [0.14, 1.24] 0.81 [0.20, 2.27] LUR
  1. Note: All-Cause Discontinuation results are on the top-right and Discontinuation Due to Adverse Events are in the bottom left. Results give the odds ratio [95% credible interval]. In the top-right comparisons, the row treatment is the reference category. In the bottom-left, the column treatment is the reference category
  2. Abbreviations: PLO Placebo, ARI Aripiprazole, CAR Cariprazine, LUR Lurasidone, OLA Olanzapine, QUE Quetiapine, ZIP Ziprasidone